絞り込み

16525

広告

「denosumab」の検索結果

2265件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Determination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritis: Mineral change by denosumab in osteoporosis with rheumatoid arthritis.

Mineral and bone disorders in conventional hemodialysis: Challenges and solutions.

Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries.

The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study.

Cellular and Molecular Mediators of Bone Metastatic Lesions.

[Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].

Evaluating the Evidence Behind Treating Osteoporosis in the Oldest Adults.

Denosumab-induced normocalcemic hyperparathyroidismin in a woman with postmenopausal osteoporosis and normal renal function.

Recurrence of Giant Cell Tumor of the Spine after Resection: A Report of 10 Cases.

Solitary juvenile xanthogranuloma in the spine pretreated with neoadjuvant denosumab therapy followed by surgical resection in a 5-year-old child: case report and literature review.

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer.

The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism.

[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]

The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

Denosumab.

The challenges of diagnosing osteoporosis and the limitations of currently available tools.

Denosumab for glucocorticoid-induced osteoporosis.

Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease.

[Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].

Cost-effectiveness Analysis of Denosumab in the Prevention of Skeletal-related Events in Patients with Prostate Cancer in Kazakhstan.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります